Phase 1B Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation
Hong, D. S., Morris, V. K., El Osta, B., Sorokin, A. V., Janku, F., Fu, S., Overman, M. J., Piha-Paul, S., Subbiah, V., Kee, B., Tsimberidou, A., Fogelman, D., Bellido, J., Shureiqi, I., Huang, H., AtLanguage:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-0050
Date:
October, 2016
File:
PDF, 1.60 MB
english, 2016